Amgen faces first Neulasta biosimilar rival as FDA approves Mylan drugAmgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar Share XAmgen faces first Neulasta biosimilar rival as FDA approves Mylan drughttps://pharmaphorum.com/news/amgen-neulasta-biosimilar-fda-mylan-fulphila/
